Preparation and Evaluation of Silymarin-Loaded Solid Eutectic for Enhanced Anti-Inflammatory, Hepatoprotective Effect: In Vitro–In Vivo Prospect

Solubility of phytochemicals is a major concern for drug delivery, permeability, and their biological response. However, advancements in the novel formulation technologies have been helping to overcome these challenges. The applications of these newer technologies are easy for commercialization and high therapeutic outcomes compared to conventional formulations. Considering these facts, the present study is aimed to prepare a silymarin-loaded eutectic mixture with three different ratios of Polyvinylpyrrolidone K30 (PVP K30) and evaluating their anti-inflammatory, and hepatoprotective effects. The preliminary phytochemical and characterization of silymarin, physical mixture, and solid dispersions suggested and successfully confirmed the formation of solid dispersion of silymarin with PVP K30. It was found that the solubility of silymarin was increased by 5-fold compared to pure silymarin. Moreover, the in vitro dissolution displayed that 83% of silymarin released within 2 h with 2.8-fold increase in dissolution rate compared to pure silymarin. Also, the in vivo study suggested that the formulation significantly reduced the carbon tetrachloride- (0.8620 ± 0.05034∗∗ for 1 : 3 ratio), paracetamol- (0.7300 ± 0.01517∗∗ for 1 : 3 ratio), and ethanol- (0.8100 ± 0.04037∗∗ for 1 : 3 ratio) induced hepatotoxicity in rats. Silymarin solid dispersion was prepared using homogenization methods that have prominent anti-inflammatory effect (0.6520 ± 0.008602∗∗ with 8.33%) in carrageenan-induced rat paw model.

[1]  Weifeng Zhu,et al.  The Novel Use of PVP K30 as Templating Agent in Production of Porous Lactose , 2021, Pharmaceutics.

[2]  Rasha Eldalawy,et al.  Phenotypic, anatomical and phytochemical investigation of Iraqi Silybum marianum , 2021 .

[3]  E. Su,et al.  Solubility improvement of phytochemicals using (natural) deep eutectic solvents and their bioactivity evaluation , 2020 .

[4]  A. Elbakry,et al.  Silymarin loaded floating polymer(s) microspheres: characterization, in-vitro/in-vivo evaluation , 2020, Pharmaceutical development and technology.

[5]  L. Tajber,et al.  Crystallo-co-spray drying as a new approach to manufacturing of drug/excipient agglomerates: impact of processing on the properties of paracetamol and lactose mixtures. , 2020, International journal of pharmaceutics.

[6]  Chengwu Shen,et al.  Electrosprayed Polymeric Nanospheres for Enhanced Solubility, Dissolution Rate, Oral Bioavailability and Antihyperlipidemic Activity of Bezafibrate , 2020, International journal of nanomedicine.

[7]  Gang Wu,et al.  Application of Solid Dispersion Technique to Improve Solubility and Sustain Release of Emamectin Benzoate , 2019, Molecules.

[8]  T. Mahmood,et al.  Silymarin-laden PVP-PEG polymeric composite for enhanced aqueous solubility and dissolution rate: Preparation and in vitro characterization , 2018, Journal of pharmaceutical analysis.

[9]  P. Deshmukh,et al.  Development of graphene-drug nanoparticle based supramolecular self assembled pH sensitive hydrogel as potential carrier for targeting MDR tuberculosis , 2019, Materials Technology.

[10]  S. Emami,et al.  Electrosprayed Nanosystems of Carbamazepine – PVP K30 for Enhancing Its Pharmacologic Effects , 2018, Iranian journal of pharmaceutical research : IJPR.

[11]  S. Nowak,et al.  Actual solubility (S|real.|), level of hydrophilic-lipophilic balance (HLBRequ., HLBD, HLBG) and partition coefficient (log P) of phytochemicals contained in Ext. Camellia sinensis L. aqu. siccum in the light of general Hildebrand-Scatchard-Fedors theory of solubility , 2018, Herba Polonica.

[12]  B. V. Robinson Pvp : A Critical Review of the Kinetics and Toxicology of Polyvinylpyrrolidone (Povidone) , 2018 .

[13]  Abhijeet Pandey,et al.  Fabrication and characterization of graphene-based hybrid nanocomposite: assessment of antibacterial potential and biomedical application , 2017, Artificial cells, nanomedicine, and biotechnology.

[14]  T. El-Elimat,et al.  Silymarin Ameliorates Diabetes-Induced Proangiogenic Response in Brain Endothelial Cells through a GSK-3β Inhibition-Induced Reduction of VEGF Release , 2017, Journal of diabetes research.

[15]  A. El-Kamel,et al.  Silymarin-Loaded Eudragit Nanoparticles: Formulation, Characterization, and Hepatoprotective and Toxicity Evaluation , 2017, AAPS PharmSciTech.

[16]  S. Sharma,et al.  Enhancement of the Solubility of Poorly Water Soluble Drugs through Solid Dispersion: A Comprehensive Review , 2017 .

[17]  S. Singh,et al.  Lipid-Drug Conjugates for Oral Bioavailability Enhancement , 2015 .

[18]  S. Beg,et al.  Lipid Microparticles for Oral Bioavailability Enhancement , 2015 .

[19]  Abualhasan Murad,et al.  Phytochemical Screening and In-vitro Evaluation of Antioxidant and Antimicrobial Activities of the Entire Khella Plant ( Ammi visnaga.L.) A member of Palestinian Flora , 2015 .

[20]  Qingnian Xu,et al.  Effects and Tolerance of Silymarin (Milk Thistle) in Chronic Hepatitis C Virus Infection Patients: A Meta-Analysis of Randomized Controlled Trials , 2014, BioMed research international.

[21]  G. Balata,et al.  Spherical agglomeration versus solid dispersion as different trials to optimize dissolution and bioactivity of silymarin , 2014 .

[22]  Jaskirat Singh,et al.  SOLUBILITY ENHANCEMENT BY SOLID DISPERSION METHOD: A REVIEW , 2013 .

[23]  F. Aqil,et al.  Bioavailability of phytochemicals and its enhancement by drug delivery systems. , 2013, Cancer letters.

[24]  Qiang Zhang,et al.  In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier , 2012, Drug development and industrial pharmacy.

[25]  Liang-Tzung Lin,et al.  Characteristics and antioxidant activities of silymarin nanoparticles. , 2012, Journal of nanoscience and nanotechnology.

[26]  Thea Koch,et al.  Lipid Mediators in Inflammatory Disorders , 1998, Drugs.

[27]  S. Das,et al.  Solid Dispersions : An Approach to Enhance the Bioa vailability of Poorly Water-Soluble Drugs , 2012 .

[28]  Yoshitada Kubo,et al.  [Stability of probucol-polyvinylpyrrolidone solid dispersion systems]. , 2011, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[29]  F. Iges,et al.  HEPATOPROTECTIVE ACTIVITIES OF ALLIUM CEPA IN CADMIUM-TREATED RATS Research Article , 2011 .

[30]  S. M. Shah,et al.  Evaluation of Phytochemicals and Antimicrobial Activity of White and Blue Capitulum and Whole Plant of Silybum Marianum , 2011 .

[31]  G. Tejal,et al.  Silymarin-solid dispersions: Characterization and influence of preparation methods on dissolution , 2010, Acta pharmaceutica.

[32]  H. Najafzadeh,et al.  Comparison of the Prophylactic Effect of Silymarin and Deferoxamine on Iron Overload-Induced Hepatotoxicity in Rat , 2010, Journal of Medical Toxicology.

[33]  K. Pillai,et al.  Diclofenac Sodium, a Nonselective Nonsteroidal Anti-Inflammatory Drug Aggravates Doxorubicin-Induced Cardiomyopathy in Rats , 2010, Journal of cardiovascular pharmacology.

[34]  K. Rock,et al.  The inflammatory response to cell death. , 2008, Annual review of pathology.

[35]  Lie-Chwen Lin,et al.  Analysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability application. , 2007, Journal of pharmaceutical and biomedical analysis.

[36]  A. Sleem,et al.  Effects of Biphenyldimethyl-dicarboxylate Administration Alone or Combined with Silymarin in the CCL4 Model of Liver Fibrosis in Rats , 2007, TheScientificWorldJournal.

[37]  Zeren Wang,et al.  Factors affecting the formation of eutectic solid dispersions and their dissolution behavior. , 2007, Journal of pharmaceutical sciences.

[38]  C. Girish,et al.  Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. , 2006, The Indian journal of medical research.

[39]  J. Juvik,et al.  Correlation analyses of phytochemical composition, chemical, and cellular measures of antioxidant activity of broccoli (Brassica oleracea L. Var. italica). , 2005, Journal of agricultural and food chemistry.

[40]  C. McClain,et al.  A Critical Involvement of Oxidative Stress in Acute Alcohol-Induced Hepatic TNF-α Production , 2003 .

[41]  L. Weber,et al.  Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model , 2003, Critical reviews in toxicology.

[42]  N. Enomoto,et al.  How is the liver primed or sensitized for alcoholic liver disease? , 2001, Alcoholism, clinical and experimental research.

[43]  M. Currie,et al.  Nitric oxide: a key mediator in the early and late phase of carrageenan‐induced rat paw inflammation , 1996, British journal of pharmacology.

[44]  N. Boughton-Smith,et al.  Role of oxygen radicals and arachidonic acid metabolites in the reverse passive Arthus reaction and carrageenin paw oedema in the rat , 1993, British journal of pharmacology.

[45]  R. O. Recknagel,et al.  Mechanisms of carbon tetrachloride toxicity. , 1989, Pharmacology & therapeutics.

[46]  R. O. Recknagel Carbon tetrachloride hepatotoxicity. , 1967, Pharmacological reviews.